Estrogen and estrogen receptors in kidney diseases

Acute kidney injury (AKI) and chronic kidney disease (CKD) are posing great threats to global health within this century. Studies have suggested that estrogen and estrogen receptors (ERs) play important roles in many physiological processes in the kidney. For instance, they are crucial in maintainin...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Renal failure Ročník 43; číslo 1; s. 619 - 642
Hlavní autori: Ma, Hao-Yang, Chen, Shuang, Du, Yang
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England Taylor & Francis 01.01.2021
Taylor & Francis Ltd
Taylor & Francis Group
Predmet:
acute kidney injury (AKI)
chronic kidney disease (CKD)
Diabetes mellitus
Endothelin 1
Estrogen
Estrogen receptors
estrogen receptors (ERs)
Estrogens
Homeostasis
IgA nephropathy
Immunoglobulin A
Kidney diseases
Lupus nephritis
Mitochondria
Nephritis
Phosphorus
Public health
Review
Signal transduction
State-of-the-Art Review
acute kidney injury (AKI)
estrogen receptors (ERs)
chronic kidney disease (CKD)
kidney diseases
Estrogen
ISSN:0886-022X, 1525-6049, 1525-6049
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Acute kidney injury (AKI) and chronic kidney disease (CKD) are posing great threats to global health within this century. Studies have suggested that estrogen and estrogen receptors (ERs) play important roles in many physiological processes in the kidney. For instance, they are crucial in maintaining mitochondrial homeostasis and modulating endothelin-1 (ET-1) system in the kidney. Estrogen takes part in the kidney repair and regeneration via its receptors. Estrogen also participates in the regulation of phosphorus homeostasis via its receptors in the proximal tubule. The ERα polymorphisms have been associated with the susceptibilities and outcomes of several renal diseases. As a consequence, the altered or dysregulated estrogen/ERs signaling pathways may contribute to a variety of kidney diseases, including various causes-induced AKI, diabetic kidney disease (DKD), lupus nephritis (LN), IgA nephropathy (IgAN), CKD complications, etc. Experimental and clinical studies have shown that targeting estrogen/ERs signaling pathways might have protective effects against certain renal disorders. However, many unsolved problems still exist in knowledge regarding the roles of estrogen and ERs in distinct kidney diseases. Further research is needed to shed light on this area and to enable the discovery of pathway-specific therapies for kidney diseases.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0886-022X
1525-6049
1525-6049
DOI:10.1080/0886022X.2021.1901739